LAUNXP BIOMEDICAL CO., LTD.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
505(b)(1) New Drug Development: Exploring new indications by repurposing approved drugs for chronic diseases in cancer treatment.
505(b)(2) Drug Repositioning: Utilizing FDA-approved drugs to identify their anticancer mechanisms, thereby shortening develo
505(b)(2) Drug Repositioning: Utilizing FDA-approved drugs to identify their anticancer mechanisms, thereby shortening develo
Founded Year
2015
Unified Business No.
54823306
Status
Active
Number of Employees
0
Total Paid-in
Capital
1,192,518,529 (NT$)
Location of Company
Taiwan
, Hsinchu County
Exit Status
Emerging Stock Exchange(2024)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
LaunXP Biomedical Co., Ltd., founded in 2015, focuses on the research and development of novel cancer therapies, dedicated to creating innovative treatments that improve patients’ quality of life.
